Richard Russell is Vice President of Biometric Research within »»ÆÞ¾ãÀÖ²¿¡¯s Global Research & Development team. Since joining the company in 2013, he has led specialist biometric research capabilities that help »»ÆÞ¾ãÀÖ²¿ anticipate and prepare for the trends shaping health, longevity, and financial stability.
Richard and his team support nearly every aspect of »»ÆÞ¾ãÀÖ²¿¡¯s business. By combining advanced analytics and biometric expertise with »»ÆÞ¾ãÀÖ²¿¡¯s extensive data and research assets, they enhance »»ÆÞ¾ãÀÖ²¿¡¯s mortality and morbidity modelling, including actuarial pricing, underwriting research, and innovation initiatives. Richard is a frequent speaker at conferences, seminars, and industry events, presenting on topics such as COVID 19 and emerging biometric trend drivers, including GLP 1 therapies and multi cancer early detection technologies.
Richard holds a Bachelor of Science in biotechnology, a Master of Science in bioinformatics (with distinction), and a Ph.D. in Statistics, all from Imperial College London. He has authored more than 30 peer reviewed publications in leading journals, including The Lancet, BMJ Open, PLOS One, and Annals of Actuarial Science.